ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy


Published in:
ONCOIMMUNOLOGY, 7, 1
Year:
2018
Laboratories:




 Record created 2018-11-08, last modified 2018-12-03


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)